Insider Trading History of Leverone Jason A.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Leverone Jason A. since 2018. This trader's CIK number is 1692747. At the time of last reporting, Leverone Jason A. was the Chief Financial Officer of Onkure Therapeutics, Inc.. (stock ticker symbol OKUR). Also see all insider trading activities at Onkure Therapeutics, Inc..

Note that in the past Leverone Jason A. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Onkure Therapeutics, Inc. (OKUR) by Leverone Jason A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 OKUR 0 $0 3,425 $9,900 0 $0

Yearly summary of insider trading at Viridian Therapeutics, Inc.\de (MGEN) by Leverone Jason A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 MGEN 0 $0 0 $0 11,249 $6,411
2019 MGEN 0 $0 0 $0 3,093 $1,763
2018 MGEN 0 $0 0 $0 29,530 $16,832


Insider trading activities at 2 companies by Leverone Jason A.:

1. Onkure Therapeutics, Inc. (OKUR)

2. Viridian Therapeutics, Inc.\de (MGEN)

Table 1. Insider trading of Onkure Therapeutics, Inc. (OKUR) by Leverone Jason A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-23 OKUR Sale 303 2.38 722
2025-04-04 OKUR Sale 1,278 3.33 4,253
2025-04-07 OKUR Sale 1,844 2.67 4,925

Table 2. Insider trading of Viridian Therapeutics, Inc.\de (MGEN) by Leverone Jason A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-03-13 MGEN Option Ex 11,249 .57 6,411
2019-08-23 MGEN Option Ex 3,093 .57 1,763
2018-08-07 MGEN Option Ex 29,530 .57 16,832

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leverone Jason A. (Chief Financial Officer of Onkure Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.